Mar 08, 2017 12:01 pm UTC| Business
- Total revenues for the full year of 2016 rose by 20.7% on a year-over-year basis. - Cloud computing revenues for the full year of 2016 increased by 230.4% on a year-over-year basis.SHENZHEN, China, March 08, 2017 --...
Mar 08, 2017 12:01 pm UTC| Business
- Total revenues for the full year of 2016 rose by 20.7% on a year-over-year basis. - Cloud computing revenues for the full year of 2016 increased by 230.4% on a year-over-year basis.SHENZHEN, China, March 08, 2017 --...
Bob Evans Reports Fiscal 2017 Third-Quarter Results; Raises Fiscal Year 2017 Guidance
Mar 08, 2017 12:01 pm UTC| Business
BEF Foods reports Q3 retail side-dish and sausage pounds sold growth of 13 percent and 3 percent, respectively. Q3 food service volume grew 19 percentRevenue from continuing operations(1) increases 4.6% to $112.8...
Bob Evans Reports Fiscal 2017 Third-Quarter Results; Raises Fiscal Year 2017 Guidance
Mar 08, 2017 12:01 pm UTC| Business
BEF Foods reports Q3 retail side-dish and sausage pounds sold growth of 13 percent and 3 percent, respectively. Q3 food service volume grew 19 percentRevenue from continuing operations(1) increases 4.6% to $112.8...
The Children’s Place Reports Fourth Quarter and Full Year 2016 Results
Mar 08, 2017 12:01 pm UTC| Business
Delivers Q4 Comparable Retail Sales Increase of 6.9% Reports Q4 GAAP Earnings per Diluted Share of $1.86, a 114% Increase vs Q4 2015 and Q4 Adjusted Earnings per Diluted Share of $1.88, a 58% Increase vs Q4 2015 ...
The Children’s Place Reports Fourth Quarter and Full Year 2016 Results
Mar 08, 2017 12:01 pm UTC| Business
Delivers Q4 Comparable Retail Sales Increase of 6.9% Reports Q4 GAAP Earnings per Diluted Share of $1.86, a 114% Increase vs Q4 2015 and Q4 Adjusted Earnings per Diluted Share of $1.88, a 58% Increase vs Q4 2015 ...
Heat Biologics Announces Agreement to Acquire Pelican Therapeutics
Mar 08, 2017 12:01 pm UTC| Business
Acquisition brings $15.2 million CPRIT grant to fund 70-patient Phase I trial DURHAM, N.C., March 08, 2017 -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a leader in the development of immunotherapies designed to...